138 related articles for article (PubMed ID: 11478055)
1. Nitric oxide and glioma: a target for novel therapy?
Shinoda J; Whittle IR
Br J Neurosurg; 2001 Jun; 15(3):213-20. PubMed ID: 11478055
[TBL] [Abstract][Full Text] [Related]
2. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
3. NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Tran AN; Boyd NH; Walker K; Hjelmeland AB
Antioxid Redox Signal; 2017 Jun; 26(17):986-999. PubMed ID: 27411305
[TBL] [Abstract][Full Text] [Related]
4. The effects of chronic nitric oxide synthase suppression on glioma pathophysiology.
Swaroop GR; Kelly PA; Bell HS; Shinoda J; Yamaguchi S; Whittle IR
Br J Neurosurg; 2000 Dec; 14(6):543-8. PubMed ID: 11272032
[TBL] [Abstract][Full Text] [Related]
5. Effects of nitric oxide manipulation on the disposition of platinum in an experimental glioma model.
Malcolm GP; Jodrell DI; MacLellan A; Swaroop GR; Kelly PA; Whittle IR
Neuroreport; 1998 Jan; 9(2):181-5. PubMed ID: 9507952
[TBL] [Abstract][Full Text] [Related]
6. Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors.
Yin D; Wang X; Konda BM; Ong JM; Hu J; Sacapano MR; Ko MK; Espinoza AJ; Irvin DK; Shu Y; Black KL
Clin Cancer Res; 2008 Jun; 14(12):4002-9. PubMed ID: 18559623
[TBL] [Abstract][Full Text] [Related]
7. The expression of nitric oxide synthases in human brain tumours and peritumoral areas.
Bakshi A; Nag TC; Wadhwa S; Mahapatra AK; Sarkar C
J Neurol Sci; 1998 Mar; 155(2):196-203. PubMed ID: 9562267
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma.
Swaroop GR; Malcolm GP; Kelly PA; Ritchie I; Whittle IR
Neuroreport; 1998 Aug; 9(11):2577-81. PubMed ID: 9721936
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
10. The implications of nitric oxide metabolism in the treatment of glial tumors.
Mazurek M; Rola R
Neurochem Int; 2021 Nov; 150():105172. PubMed ID: 34461111
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow.
Whittle IR; Collins F; Kelly PA; Ritchie I; Ironside JW
Acta Neurochir (Wien); 1996; 138(7):870-5; discussion 875-6. PubMed ID: 8869716
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour-derived iNOS in tumour progression and angiogenesis.
Kostourou V; Cartwright JE; Johnstone AP; Boult JK; Cullis ER; Whitley G; Robinson SP
Br J Cancer; 2011 Jan; 104(1):83-90. PubMed ID: 21139581
[TBL] [Abstract][Full Text] [Related]
13. Malignant glioma progression and nitric oxide.
Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ
Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
Hajri A; Metzger E; Vallat F; Coffy S; Flatter E; Evrard S; Marescaux J; Aprahamian M
Br J Cancer; 1998 Oct; 78(7):841-9. PubMed ID: 9764573
[TBL] [Abstract][Full Text] [Related]
15. The dual role of nitric oxide in glioma.
Badn W; Siesjö P
Curr Pharm Des; 2010; 16(4):428-30. PubMed ID: 20236071
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
Badn W; Hegardt P; Fellert MA; Darabi A; Esbjörnsson M; Smith KE; Janelidze S; Salford LG; Visse E; Siesjö P
Scand J Immunol; 2007 Mar; 65(3):289-97. PubMed ID: 17309784
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
18. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
19. Oedema extension in cerebral metastasis and correlation with the expression of nitric oxide synthase isozymes (NOS I-III).
Ludwig HC; Ahkavan-Shigari R; Rausch S; Schallock K; Quentin C; Ziegler D; Bockermann V; Markakis E
Anticancer Res; 2000; 20(1A):305-10. PubMed ID: 10769672
[TBL] [Abstract][Full Text] [Related]
20. Activation of nuclear factor-κB in the angiogenesis of glioma: Insights into the associated molecular mechanisms and targeted therapies.
Tu J; Fang Y; Han D; Tan X; Jiang H; Gong X; Wang X; Hong W; Wei W
Cell Prolif; 2021 Feb; 54(2):e12929. PubMed ID: 33300633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
